Eastman Chemical (EMN)
NYSE: EMN
· Real-Time Price · USD
64.02
-0.35 (-0.54%)
At close: Oct 03, 2025, 3:59 PM
64.60
0.91%
After-hours: Oct 03, 2025, 07:50 PM EDT
Eastman Chemical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 9.28B | 9.35B | 9.37B | 9.34B | 9.14B | 9.1B | 9.2B | 9.35B | 9.78B | 10.23B | 10.54B | 10.87B | 10.89B | 10.78B | 10.48B | 9.98B | 9.38B | 8.64B |
Cost of Revenue | 7.03B | 6.99B | 7.04B | 7.13B | 7.06B | 7.05B | 7.14B | 7.38B | 7.76B | 8.18B | 8.48B | 8.61B | 8.51B | 8.32B | 7.96B | 7.5B | 7.04B | 6.6B |
Gross Profit | 2.26B | 2.36B | 2.33B | 2.2B | 2.08B | 2.04B | 2.06B | 1.98B | 2.02B | 2.06B | 2.05B | 2.26B | 2.39B | 2.45B | 2.52B | 2.49B | 2.35B | 2.04B |
Operating Income | 1.29B | 1.38B | 1.34B | 1.22B | 1.12B | 1.08B | 1.1B | 1.02B | 1.05B | 1.08B | 1.07B | 1.23B | 1.33B | 1.39B | 1.47B | 1.48B | 1.39B | 1.14B |
Interest Income | 15M | 16M | 16M | 14M | 12M | 11M | 10M | 11M | 11M | 8M | 6M | 4M | 3M | 3M | 3M | 3M | 4M | 4M |
Pretax Income | 999M | 1.12B | 1.08B | 1.21B | 1.13B | 1.11B | 1.09B | 690M | 772M | 884M | 977M | 1.48B | 1.52B | 1.03B | 1.08B | 578M | 447M | 553M |
Net Income | 832M | 922M | 905M | 885M | 883M | 925M | 894M | 585M | 708M | 692M | 793M | 1.17B | 1.22B | 818M | 857M | 511M | 321M | 494M |
Selling & General & Admin | 704M | 727M | 736M | 745M | 722M | 727M | 727M | 705M | 714M | 712M | 717M | 756M | 788M | 807M | 795M | 761M | 725M | 678M |
Research & Development | 265M | 258M | 250M | 241M | 236M | 236M | 239M | 246M | 254M | 261M | 264M | 267M | 265M | 261M | 254M | 244M | 234M | 223M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 969M | 985M | 986M | 986M | 958M | 963M | 966M | 951M | 968M | 973M | 981M | 1.02B | 1.05B | 1.07B | 1.05B | 1B | 959M | 901M |
Interest Expense | 218M | 216M | 216M | 214M | 220M | 223M | 225M | 222M | 208M | 196M | 188M | 186M | 191M | 197M | 201M | 204M | 208M | 212M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8B | 7.97B | 8.03B | 8.12B | 8.02B | 8.02B | 8.1B | 8.33B | 8.73B | 9.15B | 9.46B | 9.63B | 9.56B | 9.39B | 9.01B | 8.5B | 8B | 7.5B |
Income Tax Expense | 164M | 191M | 170M | 318M | 239M | 180M | 191M | 103M | 63M | 190M | 181M | 304M | 291M | 204M | 215M | 57M | 115M | 47M |
Shares Outstanding (Basic) | 115M | 116.7M | 116.7M | 116.4M | 117.3M | 117.4M | 118M | 118.5M | 118.8M | 118.9M | 119.5M | 121M | 124.8M | 129M | 132.5M | 135.3M | 135.9M | 136.1M |
Shares Outstanding (Diluted) | 116.2M | 117.9M | 117.9M | 117.8M | 118.6M | 118.2M | 118.7M | 119M | 119.6M | 119.7M | 120.5M | 122.3M | 126.4M | 130.7M | 134.6M | 137M | 135.9M | 137.6M |
EPS (Basic) | 7.20 | 7.94 | 7.76 | 7.54 | 7.49 | 7.81 | 7.54 | 4.92 | 5.91 | 5.68 | 6.37 | 9.21 | 9.32 | 6.20 | 6.39 | 3.77 | 2.36 | 3.63 |
EPS (Diluted) | 7.12 | 7.86 | 7.68 | 7.47 | 7.43 | 7.76 | 7.49 | 4.89 | 5.86 | 5.62 | 6.30 | 9.10 | 9.21 | 6.11 | 6.30 | 3.72 | 2.33 | 3.60 |
EBITDA | 1.72B | 1.84B | 1.8B | 1.92B | 1.83B | 1.81B | 1.81B | 1.41B | 1.47B | 1.57B | 1.63B | 2.13B | 2.19B | 1.73B | 1.81B | 1.33B | 1.23B | 1.34B |
EBIT | 1.21B | 1.33B | 1.29B | 1.42B | 1.34B | 1.33B | 1.31B | 910M | 978M | 1.07B | 1.15B | 1.65B | 1.69B | 1.22B | 1.27B | 773M | 646M | 756M |
Depreciation & Amortization | 509M | 508M | 509M | 498M | 491M | 484M | 498M | 497M | 494M | 497M | 477M | 482M | 492M | 510M | 538M | 561M | 583M | 584M |